The CYP3A5 genotypes of both liver transplant recipients and donors influence the time-dependent recovery of tacrolimus clearance during the early stage following transplantation

Huang, LiAssiri, Abdullah A.Wen, PeihaoZhang, KunFan, JunweiXing, TonghaiLiu, YuanZhang, JinyanWang, ZhaowenSu, ZhaojieChen, JiajiaXiao, YiWang, RuiNa, RisiYuan, LiyunLiu, DehuaXia, JunjieZhong, LinLiu, WanqingGuo, WenzhiOverholser, Brian R.Peng, Zhihai2023-03-232023-03-232021-10Huang L, Assiri AA, Wen P, et al. The CYP3A5 genotypes of both liver transplant recipients and donors influence the time-dependent recovery of tacrolimus clearance during the early stage following transplantation. Clin Transl Med. 2021;11(10):e542. doi:10.1002/ctm2.542https://hdl.handle.net/1805/32046en-USAttribution 4.0 InternationalCytochrome P-450 CYP3AImmunosuppressive agentsLiver transplantationTacrolimusTransplant recipientsThe CYP3A5 genotypes of both liver transplant recipients and donors influence the time-dependent recovery of tacrolimus clearance during the early stage following transplantationArticle